PT  - JOURNAL ARTICLE
AU  - Gross, Bnaya
AU  - Zheng, Zhiguo
AU  - Liu, Shiyan
AU  - Chen, Xiaoqi
AU  - Sela, Alon
AU  - Li, Jianxin
AU  - Li, Daqing
AU  - Havlin, Shlomo
TI  - Spatio-temporal propagation of COVID-19 pandemics
AID  - 10.1101/2020.03.23.20041517
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.23.20041517
4099  - http://medrxiv.org/content/early/2020/03/27/2020.03.23.20041517.short
4100  - http://medrxiv.org/content/early/2020/03/27/2020.03.23.20041517.full
AB  - The new coronavirus known as COVID-19 is rapidly spreading since December 2019. Without any vaccination or medicine, the means of controlling it are limited to quarantine and social distancing. Here we study the spatio-temporal propagation of the COVID-19 virus in China and compare it to other global locations. Our results suggest that the disease propagation is highly related to population migration from Hubei resembling a Lévy flight which is characteristic of human mobility and thus could be controlled by efficient quarantines. Since quarantine is usually applied on a city level, more insight can be obtained in analyzing the epidemic in cities. Our results suggest that the disease spread in a city in China is characterized by two-stages process. At early times, at order of few days, the infection rate in the city is close to constant probably due to the lack of means to detect infected individuals before infection signs are observed and at later times it decays approximately exponentially due to quarantines. These two stages can explain the significant differences between the propagation in China and in other world-wide locations. While most Chinese cities control the disease which resulted in the decaying stage, in other world-wide countries the situation is still becoming worse probably due to less control.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe thank the Israel Science Foundation, ONR, the BIU Center for Research in Applied Cryptography and Cyber Security, and DTRA Grant no. HDTRA-1-19-1-0016 for financial support.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data available online